President Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals. Some, like ending birthright citizenship, are quickly slapped down in ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Scope Industries (OTCMKTS:SCPJ – Get Free Report)’s share price dropped 3.8% during trading on Tuesday . The stock traded as low as $303.00 and last traded at $303.00. Approximately 66 shares changed ...

Tracey Allen Franks, age 59, of Indianapolis, IN, was born on Nov. 26, 1965, in Seymour, IN, to parents Bruce and Virginia ...

K-Bio leaders pursue U.S. factories and conferences during Lunar New Year K-Bio executives opt for international business ...

LOS ANGELES (KTLA) – With the devastating Palisades Fire still smoldering, Lisa Pelton and some of her neighbors in ...

Online master’s degrees in engineering and education from Purdue again rank among the nation’s finest. Four of Pur ...

Rare disease drug maker Pharming Group is calling off the search for a CEO successor to longtime chief Sijmen de Vries after ...

The nature of the beast is yes, these drugs come off patent; the demand is there and someone could produce it more cheaply’, ...

There are several potential challengers to Novo Nordisk and Eli Lilly’s obesity drugs, and Jefferies analysts see one as particularly promising.

View Eli Lilly and Company (LLY) current and estimated P/E ratio data provided by Seeking Alpha.

Deep-pocketed investors have adopted a bearish approach towards Eli Lilly LLY, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this ...